Organ-on-a-Chip Market Size, Share, Trends, Industry Analysis Report By Product & Services (Products, Services), By Application, By End Use, By Region – Market Forecast, 2025–2034
Description
The global organ-on-a-chip market size is expected to reach USD 3,262.08 million by 2034, according to a new study by Polaris Market Research. The report “Organ-on-a-Chip Market Size, Share, Trends, Industry Analysis Report By Product & Services (Products, Services), By Application, By End Use, By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The organ-on-a-chip market is centered on a technology that uses microfluidic devices to simulate the structure and function of human organs. These small platforms, often no larger than a computer memory stick, are made with tiny channels lined with living human cells. The goal is to create a more realistic and controlled environment for research than traditional methods such as 3D cell cultures or animal testing. This allows scientists to observe how organs behave, model diseases, and study the effects of drugs in a way that is highly relevant to human biology.
The organ-on-a-chip market is mainly driven by the need for new solutions in drug development and toxicology research. As the pharmaceutical industry works to make drug discovery more efficient and reduce the high failure rate of clinical trials, this technology offers a valuable tool for early-stage testing. At the same time, growing ethical concerns and government regulations are pushing for alternatives to animal testing, which has increased demand for these systems. The market is also seeing new trends, such as the use of these chips in personalized medicine and a rising number of collaborations between technology developers and research institutions.
Organ-on-a-Chip Market Report Highlights
By product & services, the products segment held the largest share in 2024. This is mainly attributed to the essential nature of the physical devices, instruments, and consumables that form the foundation of this technology and are crucial for all research and testing applications.
By application, the drug discovery segment held the largest share in 2024. This is because of its critical role in the pharmaceutical industry's efforts to develop new medications more efficiently and reduce the high rate of drug failures in late-stage clinical trials.
In terms of end use, the pharmaceutical and biotechnology companies segment held the largest share in 2024. Their significant investments in research and development, particularly for improving drug discovery and toxicology screening, drive their leading position in the industry.
North America is the leading region in the global market. The region's strong presence of major pharmaceutical and biotechnology companies and its significant funding for research and development are key factors driving its dominance. The Asia Pacific market is expanding rapidly, with a growing number of countries investing in the life sciences and healthcare sectors.
A few key players in the market include Emulate, Inc.; MIMETAS BV; TissUse GmbH; CN Bio Innovations Ltd.; InSphero AG; Nortis, Inc.; Hesperos, Inc.; AxoSim, Inc.; Hµrel Corporation; and Tara Biosystems, Inc. (Charles River Laboratories).
Polaris Market Research has segmented the organ-on-a-chip market report based on product & services, application, end use, and region:
By Product & Services Outlook (Revenue – USD Million, 2020–2034)
Products
Services
By Application Outlook (Revenue – USD Million, 2020–2034)
Drug Discovery
Toxicology Research
Others
By End Use Outlook (Revenue – USD Million, 2020–2034)
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Others
By Regional Outlook (Revenue – USD Million, 2020–2034)
North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
The organ-on-a-chip market is centered on a technology that uses microfluidic devices to simulate the structure and function of human organs. These small platforms, often no larger than a computer memory stick, are made with tiny channels lined with living human cells. The goal is to create a more realistic and controlled environment for research than traditional methods such as 3D cell cultures or animal testing. This allows scientists to observe how organs behave, model diseases, and study the effects of drugs in a way that is highly relevant to human biology.
The organ-on-a-chip market is mainly driven by the need for new solutions in drug development and toxicology research. As the pharmaceutical industry works to make drug discovery more efficient and reduce the high failure rate of clinical trials, this technology offers a valuable tool for early-stage testing. At the same time, growing ethical concerns and government regulations are pushing for alternatives to animal testing, which has increased demand for these systems. The market is also seeing new trends, such as the use of these chips in personalized medicine and a rising number of collaborations between technology developers and research institutions.
Organ-on-a-Chip Market Report Highlights
By product & services, the products segment held the largest share in 2024. This is mainly attributed to the essential nature of the physical devices, instruments, and consumables that form the foundation of this technology and are crucial for all research and testing applications.
By application, the drug discovery segment held the largest share in 2024. This is because of its critical role in the pharmaceutical industry's efforts to develop new medications more efficiently and reduce the high rate of drug failures in late-stage clinical trials.
In terms of end use, the pharmaceutical and biotechnology companies segment held the largest share in 2024. Their significant investments in research and development, particularly for improving drug discovery and toxicology screening, drive their leading position in the industry.
North America is the leading region in the global market. The region's strong presence of major pharmaceutical and biotechnology companies and its significant funding for research and development are key factors driving its dominance. The Asia Pacific market is expanding rapidly, with a growing number of countries investing in the life sciences and healthcare sectors.
A few key players in the market include Emulate, Inc.; MIMETAS BV; TissUse GmbH; CN Bio Innovations Ltd.; InSphero AG; Nortis, Inc.; Hesperos, Inc.; AxoSim, Inc.; Hµrel Corporation; and Tara Biosystems, Inc. (Charles River Laboratories).
Polaris Market Research has segmented the organ-on-a-chip market report based on product & services, application, end use, and region:
By Product & Services Outlook (Revenue – USD Million, 2020–2034)
Products
Services
By Application Outlook (Revenue – USD Million, 2020–2034)
Drug Discovery
Toxicology Research
Others
By End Use Outlook (Revenue – USD Million, 2020–2034)
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Others
By Regional Outlook (Revenue – USD Million, 2020–2034)
North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
115 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source
- 4. Global Organ-on-a-Chip Market Insights
- 4.1. Organ-on-a-Chip Market – Market Snapshot
- 4.2. Organ-on-a-Chip Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. The Demand for Safer and More Effective Drug Discovery
- 4.2.1.2. Push for Alternatives to Animal Testing
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High development cost and complexity
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Organ-on-a-Chip Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Organ-on-a-Chip Market, by Product and Services
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 5.3. Products
- 5.3.1. Global Organ-on-a-Chip Market, by Elements, by Region, 2020–2034 (USD Million)
- 5.3.2. Instrument
- 5.3.3. Devices
- 5.3.3.1. Liver-on-a-Chip
- 5.3.3.2. Lung-on-a-Chip
- 5.3.3.3. Intestine-on-a-Chip
- 5.3.3.4. Kidney-on-a-Chip
- 5.3.3.5. Heart-on-a-Chip
- 5.3.3.6. Others
- 5.4. Services
- 5.4.1. Global Organ-on-a-Chip Market, by Chemicals, by Region, 2020–2034 (USD Million)
- 6. Global Organ-on-a-Chip Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 6.3. Drug Discovery
- 6.3.1. Global Organ-on-a-Chip Market, by Drug Discovery, by Region, 2020–2034 (USD Million)
- 6.4. Toxicology Research
- 6.4.1. Global Organ-on-a-Chip Market, by Toxicology Research, by Region, 2020–2034 (USD Million)
- 6.5. Others
- 6.5.1. Global Organ-on-a-Chip Market, by Others, by Region, 2020–2034 (USD Million)
- 7. Global Organ-on-a-Chip Market, by End Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 7.3. Academic & Research Institutes
- 7.3.1. Global Organ-on-a-Chip Market, by Academic & Research Institutes, by Region, 2020–2034 (USD Million)
- 7.4. Pharmaceutical & Biotechnology Companies
- 7.4.1. Global Organ-on-a-Chip Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020–2034 (USD Million)
- 7.5. Others
- 7.5.1. Global Organ-on-a-Chip Market, by Others, by Region, 2020–2034 (USD Million)
- 8. Global Organ-on-a-Chip Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Organ-on-a-Chip Market Assessment, By Geography, 2020–2034 (USD Million)
- 8.3. Organ-on-a-Chip Market – North America
- 8.3.1. North America: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.3.2. North America: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.3.3. North America: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.3.4. Organ-on-a-Chip Market – U.S.
- 8.3.4.1. U.S.: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.3.4.2. U.S.: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.3.4.3. U.S.: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.3.5. Organ-on-a-Chip Market – Canada
- 8.3.5.1. Canada: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.3.5.2. Canada: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.3.5.3. Canada: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.4. Organ-on-a-Chip Market – Europe
- 8.4.1. Europe: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.4.2. Europe: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.4.3. Europe: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.4.4. Organ-on-a-Chip Market – UK
- 8.4.4.1. UK: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.4.4.2. UK: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.4.4.3. UK: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.4.5. Organ-on-a-Chip Market – France
- 8.4.5.1. France: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.4.5.2. France: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.4.5.3. France: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.4.6. Organ-on-a-Chip Market – Germany
- 8.4.6.1. Germany: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.4.6.2. Germany: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.4.6.3. Germany: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.4.7. Organ-on-a-Chip Market – Italy
- 8.4.7.1. Italy: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.4.7.2. Italy: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.4.7.3. Italy: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.4.8. Organ-on-a-Chip Market – Spain
- 8.4.8.1. Spain: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.4.8.2. Spain: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.4.8.3. Spain: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.4.9. Organ-on-a-Chip Market – Netherlands
- 8.4.9.1. Netherlands: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.4.9.2. Netherlands: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.4.9.3. Netherlands: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.4.10. Organ-on-a-Chip Market – Russia
- 8.4.10.1. Russia: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.4.10.2. Russia: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.4.10.3. Russia: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.4.11. Organ-on-a-Chip Market – Rest of Europe
- 8.4.11.1. Rest of Europe: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.4.11.2. Rest of Europe: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.4.11.3. Rest of Europe: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.5. Organ-on-a-Chip Market – Asia Pacific
- 8.5.1. Asia Pacific: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.5.2. Asia Pacific: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.5.3. Asia Pacific: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.5.4. Organ-on-a-Chip Market – China
- 8.5.4.1. China: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.5.4.2. China: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.5.4.3. China: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.5.5. Organ-on-a-Chip Market – India
- 8.5.5.1. India: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.5.5.2. India: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.5.5.3. India: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.5.6. Organ-on-a-Chip Market – Malaysia
- 8.5.6.1. Malaysia: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.5.6.2. Malaysia: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.5.6.3. Malaysia: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.5.7. Organ-on-a-Chip Market – Japan
- 8.5.7.1. Japan: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.5.7.2. Japan: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.5.7.3. Japan: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.5.8. Organ-on-a-Chip Market – Indonesia
- 8.5.8.1. Indonesia: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.5.8.2. Indonesia: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.5.8.3. Indonesia: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.5.9. Organ-on-a-Chip Market – South Korea
- 8.5.9.1. South Korea: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.5.9.2. South Korea: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.5.9.3. South Korea: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.5.10. Organ-on-a-Chip Market – Australia
- 8.5.10.1. Australia: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.5.10.2. Australia: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.5.10.3. Australia: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.5.11. Organ-on-a-Chip Market – Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.5.11.2. Rest of Asia Pacific: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.5.11.3. Rest of Asia Pacific: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.6. Organ-on-a-Chip Market – Middle East & Africa
- 8.6.1. Middle East & Africa: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.6.2. Middle East & Africa: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.6.3. Middle East & Africa: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.6.4. Organ-on-a-Chip Market – Saudi Arabia
- 8.6.4.1. Saudi Arabia: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.6.4.2. Saudi Arabia: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.6.4.3. Saudi Arabia: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.6.5. Organ-on-a-Chip Market – UAE
- 8.6.5.1. UAE: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.6.5.2. UAE: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.6.5.3. UAE: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.6.6. Organ-on-a-Chip Market – Israel
- 8.6.6.1. Israel: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.6.6.2. Israel: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.6.6.3. Israel: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.6.7. Organ-on-a-Chip Market – South Africa
- 8.6.7.1. South Africa: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.6.7.2. South Africa: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.6.7.3. South Africa: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.6.8. Organ-on-a-Chip Market – Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.6.8.2. Rest of Middle East & Africa: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.6.8.3. Rest of Middle East & Africa: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.7. Organ-on-a-Chip Market – Latin America
- 8.7.1. Latin America: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.7.2. Latin America: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.7.3. Latin America: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.7.4. Organ-on-a-Chip Market – Mexico
- 8.7.4.1. Mexico: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.7.4.2. Mexico: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.7.4.3. Mexico: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.7.5. Organ-on-a-Chip Market – Brazil
- 8.7.5.1. Brazil: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.7.5.2. Brazil: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.7.5.3. Brazil: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.7.6. Organ-on-a-Chip Market – Argentina
- 8.7.6.1. Argentina: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.7.6.2. Argentina: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.7.6.3. Argentina: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.7.7. Organ-on-a-Chip Market – Rest of Latin America
- 8.7.7.1. Rest of Latin America: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.7.7.2. Rest of Latin America: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.7.7.3. Rest of Latin America: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
- 10. Company Profiles
- 10.1. AxoSim, Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. CN Bio Innovations Ltd.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Emulate, Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Hesperos, Inc.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Hµrel Corporation
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. InSphero AG
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. MIMETAS BV
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Nortis, Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Tara Biosystems, Inc. (Charles River Laboratories)
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. TissUse GmbH
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
